The Economic Times daily newspaper is available online now.

    Suven Life Sciences to set up subsidiary in US, to infuse $75 million

    Synopsis

    The board of directors has approved investment of USD 75 million in the said WOS for new business opportunities and acquisitions,the company said.

    AgenciesAgencies
    The board of directors has approved investment of USD 75 million in the said WOS for new business opportunities and acquisitions,the company said.
    NEW DELHI: Suven Life Sciences Saturday said it will create a wholly-owned subsidiary in the US and will infuse USD 75 million (about Rs 525 crore) in its new business.

    The board of directors at its meeting held on Saturday has taken on record the approval for creation of wholly owned subsidiary (WOS) Suven Pharma, Inc, a
    Delaware company in the US under Contract Research And Manufacturing Services (CRAMS) division, the company said in a regulatory filing.

    The board of directors has approved investment of USD 75 million in the said WOS for new business opportunities and acquisitions, it added.


    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    ...more

    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    ...more
    The Economic Times

    Stories you might be interested in